The use of CytoSorb® in a prasugrel‐loaded patient undergoing emergent coronary artery bypass graft surgery
Abstract Patients with acute coronary syndrome (ACS), failed percutaneous coronary intervention (PCI) and with an indication for emergent coronary artery bypass graft surgery (CABG) are at an increased risk of perioperative bleeding. Integration of the CytoSorb® (CS) adsorber into the cardiopulmonar...
Saved in:
| Main Authors: | Erich Moresco, Hannes Dejaco, Volker Humbert, Matthias Thoma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-03-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.6990 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Clinical Use of CytoSorb<sup>®</sup> for Ticagrelor and Rivaroxaban Elimination Prior to Emergency Orthopedic Surgery in Trauma Patients
by: Gabriele Melegari, et al.
Published: (2025-07-01) -
CytoSorb<sup>®</sup> Hemadsorption in Cardiogenic Shock: A Real-World Analysis of Hemodynamics, Organ Function, and Clinical Outcomes During Mechanical Circulatory Support
by: Julian Kreutz, et al.
Published: (2025-01-01) -
Impact of hemoadsorption with CytoSorb® on meropenem and piperacillin exposure in critically ill patients in a post-CKRT setup: a single-center, retrospective data analysis
by: Golschan Asgarpur, et al.
Published: (2025-01-01) -
Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry
by: Michael Schmoeckel, et al.
Published: (2025-01-01) -
Decreased vasoregulatory dysfunction associated with intra-operative hemoadsorption treatment is related to mitigated post-transplant procalcitonin rather than cytokine or complement response
by: Hajna Katona, et al.
Published: (2025-08-01)